Have a personal or library account? Click to login
The Role of GLP 1 Receptor Agonists in Treating Heart Failure: Useful or Not? Cover

The Role of GLP 1 Receptor Agonists in Treating Heart Failure: Useful or Not?

Internal Medicine
Volume 21 (2024): Issue 1 (March 2024)
By: Laura Lungeanu-Juravle,  Andra Nica,  Emilia Rusu and  Gabriela Radulian  
Open Access
|Mar 2024
DOI: https://doi.org/10.2478/inmed-2024-0276 | Journal eISSN: 1220-5818 | Journal ISSN: 1220-5818
Journal RSS Feed
Language: English
Page range: 39 - 47
Published on: Mar 29, 2024
Published by: Romanian Society of Internal Medicine
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
heart failure (HF),
diabetes mellitus type 2 (T2DM),
Glucagon-like peptide-1 receptor agonists (GLP-1 Ras).
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Internal medicine, other,
Cardiology,
Gastroenterology,
Pneumology

© 2024 Laura Lungeanu-Juravle, Andra Nica, Emilia Rusu, Gabriela Radulian, published by Romanian Society of Internal Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 21 (2024): Issue 1 (March 2024)Next article